Breast cancer detection tool from Parascript wins FDA nod

09/6/2013 | American City Business Journals

The FDA has granted Parascript approval for its AccuDetect software, designed to aid in early breast cancer diagnosis. In an analysis, the technology helped improve the detection of tumors missed in initial exams by 18.8% and achieved a 14.2% reduction in the number of follow-up tests from false positives, the company said.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN